Encouraging human T-cells.NIAID, CC BYPembrolizumab, an immunotherapy treatment initially approved for advanced melanoma, recently became the first drug to be approved through the UK’s early access to medicine scheme, which gives patients with life threatening or serious conditions access to medicines that are unlicensed or off-label.
The...
More...
